TP53 and cancer: Furthermore, Schauer et al. showed that elevated expression and secretion of interleukin-1β (IL-1β) from EOC cells, and overexpression of its receptor IL-1R1 in cancer-associated fibroblasts (CAFs), resulted in attenuated p53 expression in CAFs.